申请人:ACUITAS THERAPEUTICS, INC.
公开号:US20200172472A1
公开(公告)日:2020-06-04
Compounds are provided having the following structure (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R
1a
, R
1b
, R
2a
, R
2b
, R
3a
, R
3b
, R
4a
, R
4b
, R
5
, R
6
, R
7
, R
8
, L
1
, L
2
, G
1
, G
2
, G
3
, a, b, c and d are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.